Company intelligence / Profile preview

Signet Laboratories

Dedham, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

Signet Laboratories was a prominent provider of monoclonal antibodies and diagnostic reagents, specializing in the fields of oncology, neurodegenerative disease, and infectious disease. Founded in 1989 and based in Dedham, Massachusetts, the company became widely recognized for its high-quality immunohistochemistry (IHC) products and its extensive catalog of antibodies for Alzheimer's research, including Beta-Amyloid and Tau. In 2006, Signet was acquired by Covance for approximately $40 million to enhance Covance's biomarker and antibody services. Today, its legacy products and expertise are integrated into LabCorp's drug development and diagnostic offerings.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Monoclonal antibodyReagents
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Signet Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signet Laboratories.

Explore the full profile